{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-019579","form_type":"8-K","ticker":"ENVB","cik":"0000890821","company_name":"Enveric Biosciences, Inc.","filed_at":"2022-07-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.470169+00:00","generated_at":"2026-06-24T13:48:20.689286+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"medium","headline":"Enveric Biosciences appoints Frank Pasqualone to Board, effective July 13, 2022","bullets":["Frank Pasqualone appointed to board, filling vacancy from size increase from 8 to 9 directors.","Term expires at 2022 annual meeting; successor to be elected or until earlier resignation.","No arrangements with any person or reportable transactions under Item 404(a)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-019579","json":"https://secwatch.observer/filing/0001493152-22-019579.json","markdown":"https://secwatch.observer/filing/0001493152-22-019579.md","text":"https://secwatch.observer/filing/0001493152-22-019579.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/890821/000149315222019579/0001493152-22-019579-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/890821/000149315222019579/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T13:48:20.689286+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5690dc7f47","claim":"Frank Pasqualone was appointed as Director at Enveric Biosciences, Inc..","evidence_excerpt":"On July 13, 2022, Frank Pasqualone was appointed to the board of directors (the “Board”) of Enveric Biosciences, Inc. (the “Company”), to serve as a director of the Board, to fill a vacancy as a result of the increase in the size of the Board from eight to nine persons, effective as of the same date","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/890821/000149315222019579/0001493152-22-019579-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}